nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—ADRA1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00381	0.00381	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00375	0.00375	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00372	0.00372	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00366	0.00366	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.0036	0.0036	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00354	0.00354	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00353	0.00353	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00352	0.00352	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00346	0.00346	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.0034	0.0034	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—SPARC—adrenal gland cancer	0.00335	0.00335	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00334	0.00334	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00321	0.00321	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00321	0.00321	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—SPARC—adrenal gland cancer	0.00313	0.00313	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—SDHB—adrenal gland cancer	0.00305	0.00305	CbGpPWpGaD
Tolazoline—ADRA1A—AMPK Signaling—TP53—adrenal gland cancer	0.00294	0.00294	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—POMC—adrenal gland cancer	0.00293	0.00293	CbGpPWpGaD
Tolazoline—ADRA2B—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00285	0.00285	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—PRKACA—adrenal gland cancer	0.00283	0.00283	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00279	0.00279	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00276	0.00276	CbGpPWpGaD
Tolazoline—ADRA2C—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00266	0.00266	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—PRKACA—adrenal gland cancer	0.00264	0.00264	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00261	0.00261	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00258	0.00258	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00256	0.00256	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00255	0.00255	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—SPARC—adrenal gland cancer	0.00254	0.00254	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00253	0.00253	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GNRHR—adrenal gland cancer	0.0025	0.0025	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00249	0.00249	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—SDHB—adrenal gland cancer	0.00248	0.00248	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00246	0.00246	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—CDC42—adrenal gland cancer	0.0024	0.0024	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—GNAS—adrenal gland cancer	0.00239	0.00239	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00237	0.00237	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00234	0.00234	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GNRHR—adrenal gland cancer	0.00233	0.00233	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00233	0.00233	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00232	0.00232	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00232	0.00232	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00232	0.00232	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—IGF2—adrenal gland cancer	0.00231	0.00231	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—GNAS—adrenal gland cancer	0.00229	0.00229	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00228	0.00228	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TSHR—adrenal gland cancer	0.00227	0.00227	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00226	0.00226	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00226	0.00226	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—CDC42—adrenal gland cancer	0.00224	0.00224	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00223	0.00223	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00218	0.00218	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00217	0.00217	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00216	0.00216	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—IGF2—adrenal gland cancer	0.00216	0.00216	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—PRKACA—adrenal gland cancer	0.00214	0.00214	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—GNAS—adrenal gland cancer	0.00214	0.00214	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MEN1—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00209	0.00209	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00208	0.00208	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00204	0.00204	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00204	0.00204	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—RRM1—adrenal gland cancer	0.00197	0.00197	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—SDHD—adrenal gland cancer	0.00197	0.00197	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00192	0.00192	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00189	0.00189	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00184	0.00184	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00178	0.00178	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00176	0.00176	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	0.00174	0.00174	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—POMC—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00172	0.00172	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00171	0.00171	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00166	0.00166	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—POMC—adrenal gland cancer	0.00166	0.00166	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PRKACA—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00162	0.00162	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—POMC—adrenal gland cancer	0.00161	0.00161	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—RRM1—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—SDHD—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00151	0.00151	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00151	0.00151	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—POMC—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—MED12—adrenal gland cancer	0.00147	0.00147	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00144	0.00144	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	0.00143	0.00143	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CDC42—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00135	0.00135	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00135	0.00135	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TSHR—adrenal gland cancer	0.00133	0.00133	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IGF2—adrenal gland cancer	0.00133	0.00133	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00132	0.00132	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—GNAS—adrenal gland cancer	0.00132	0.00132	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IGF1R—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MEN1—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TSHR—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00124	0.00124	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—MED12—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MEN1—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TERT—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PRKACA—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000997	0.000997	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000974	0.000974	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—BAD—adrenal gland cancer	0.000964	0.000964	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000958	0.000958	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000952	0.000952	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.00091	0.00091	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000895	0.000895	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—POMC—adrenal gland cancer	0.000889	0.000889	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000885	0.000885	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—BRAF—adrenal gland cancer	0.000878	0.000878	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000869	0.000869	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.000867	0.000867	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.000851	0.000851	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000851	0.000851	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000827	0.000827	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000813	0.000813	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000811	0.000811	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000797	0.000797	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000796	0.000796	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000783	0.000783	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000782	0.000782	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000776	0.000776	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000759	0.000759	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000757	0.000757	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000739	0.000739	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	0.000736	0.000736	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000732	0.000732	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000732	0.000732	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000727	0.000727	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000725	0.000725	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000723	0.000723	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000707	0.000707	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000704	0.000704	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000691	0.000691	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000684	0.000684	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.000676	0.000676	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000671	0.000671	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000664	0.000664	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000652	0.000652	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000652	0.000652	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.000646	0.000646	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.00064	0.00064	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000634	0.000634	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000634	0.000634	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00063	0.00063	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000618	0.000618	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000616	0.000616	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000609	0.000609	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000594	0.000594	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000589	0.000589	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000584	0.000584	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000575	0.000575	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000567	0.000567	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000555	0.000555	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TERT—adrenal gland cancer	0.000542	0.000542	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000532	0.000532	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.00053	0.00053	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000523	0.000523	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000516	0.000516	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EGFR—adrenal gland cancer	0.000503	0.000503	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.0005	0.0005	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000495	0.000495	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000488	0.000488	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000482	0.000482	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000474	0.000474	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—BAD—adrenal gland cancer	0.000472	0.000472	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000467	0.000467	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.000466	0.000466	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000463	0.000463	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—POMC—adrenal gland cancer	0.000435	0.000435	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.00043	0.00043	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	0.00043	0.00043	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000427	0.000427	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TP53—adrenal gland cancer	0.000422	0.000422	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000422	0.000422	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000416	0.000416	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000409	0.000409	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000397	0.000397	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000392	0.000392	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.00038	0.00038	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	0.000378	0.000378	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000373	0.000373	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000348	0.000348	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00031	0.00031	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000305	0.000305	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000296	0.000296	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000283	0.000283	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000276	0.000276	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	0.000248	0.000248	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	0.000246	0.000246	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000241	0.000241	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	0.000232	0.000232	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	0.000224	0.000224	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TP53—adrenal gland cancer	0.000207	0.000207	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	0.000203	0.000203	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	0.000188	0.000188	CbGpPWpGaD
